Aura Biosciences Inc (AURA) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aura Biosciences Inc   (NASDAQ: AURA)


Aura Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aura Biosciences Inc's ROI in the second quarter of 2026?
Aura Biosciences Inc recorded a cumulative net loss of $-131 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -67.9%.

Within the Healthcare sector 555 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 3907, from total ROI ranking in the first quarter of 2026 at 4511.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 11.69 % -10.78 % -17.22 % -22.49 % -18.19 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 329 121 151 171 190
Return On Investment (TTM) -67.9 % -71.05 % -64.85 % -63.41 % -58.68 %
AURA's Overall Ranking # 3907 # 4511 # 3959 # 3967 # 3952
Seq. Investment Change TTM 21.97 % -3.4 % -2.46 % -2.81 % -2.56 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -131 -112 -106 -106 -101

AURA Company Profile >> Back to AURA Roi Comparisons >> See Annual AURA Return On Investment



Return On Investment AURA's Ranking
Within: No.
Industry # 86
Sector # 556
Overall # 3907

Return On Investment Statistics
High Average Low
-36.81 %
-62.63 %
-279.71 %
(Sep 30 2023)   (Dec 31 2021)







Financial Statements
Aura Biosciences Inc's II. Quarter Investments $ 329 Millions AURA's Balance sheet
Aura Biosciences Inc's II. Quarter Income $ -46 Millions Quarterly AURA's Income Statement
AURA's Income by Division See AURA's Income by Division


AURA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 151 168 243 213 153
Y / Y Investment Growth -9.87 % -30.95 % 13.7 % 39.75 % -
Net Income in Millions -106 -87 -76 -59 -35
Y / Y Net Income Growth - - - - -
Annual Return On Investment -70.3 % -51.86 % -31.48 % -27.53 % -23.08 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AURA's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AURA's Competitors
Subscribers only: Roi for Aura Biosciences Inc's Suppliers
Subscribers only: Return On Investment for AURA's Customers

Other Ratios
AURA's Roa AURA's Inventory Turnover Ratio AURA's Growth Rates AURA's Dividend Statistics
AURA's Profitability Ratios AURA's Asset Turnover Ratio AURA's Dividend Growth
AURA's Roe AURA's Valuation Ratios AURA's Financial Strength Ratios AURA's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-05T14:56:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.